Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| iPSC-Derived Hepatocytes from Patients with MASLD Exhibit Early Mitochondrial Dysfunction. | bioRxiv | 2025 | 40909581 | PubTator, text mining | PubMed |
Patatin-Like Phospholipase Domain-Containing Protein 3 (PNPLA3) rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights. | Clin Exp Gastroenterol | 2025 | 40904834 | PubTator, text mining | PubMed |
| Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients. | Clin Exp Hepatol | 2025 | 40904655 | PubTator, text mining | PubMed |
| Organelle bridges and nanodomain partitioning govern targeting of membrane-embedded proteins to lipid droplets. | bioRxiv | 2025 | 40894689 | PubTator, text mining | PubMed |
| Call a spade a spade. | Hepatobiliary Surg Nutr | 2025 | 40893747 | PubTator, text mining | PubMed |
| Association Between PNPLA3 Inhibition and Gout: A Drug Target Mendelian Randomization Study. | Int J Endocrinol | 2025 | 40881642 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis. | Hepatol Commun | 2025 | 40879475 | PubTator, text mining | PubMed |
| Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults. | Biomedicines | 2025 | 40868230 | PubTator, text mining | PubMed |
| Genetic Risk of MASLD in Mongolians: Role of PNPLA3 and FTO SNPs. | Curr Issues Mol Biol | 2025 | 40864759 | PubTator, text mining | PubMed |
| Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-Analysis. | Liver Int | 2025 | 40851509 | PubTator, text mining | PubMed |
| Molecular Characterization of Patatin-Like Phospholipase Domain-Containing 3 (PNPLA3) Gene in Alcoholic Liver Disease. | Cureus | 2025 | 40831836 | PubTator, text mining | PubMed |
| Association between metabolic dysfunction-associated steatotic liver disease and cardiovascular disease: New perspectives. | Medicine (Baltimore) | 2025 | 40826756 | PubTator, text mining | PubMed |
| Mendelian randomization identifies genetically predicted calorie dietary preference as causal risk factors for cancer. | Discov Oncol | 2025 | 40825912 | PubTator, text mining | PubMed |
| Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes. | Front Med (Lausanne) | 2025 | 40823550 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development. | JHEP Rep | 2025 | 40823170 | PubTator, text mining | PubMed |
| Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino children. | Matern Health Neonatol Perinatol | 2025 | 40814062 | PubTator, text mining | PubMed |
| Contribution of PNPLA3, GCKR, MBOAT7, NCAN, and TM6SF2 Genetic Variants to Hepatocellular Carcinoma Development in Mexican Patients. | Int J Mol Sci | 2025 | 40806538 | PubTator, text mining | PubMed |
| Adding salt to foods increases the risk of metabolic dysfunction-associated steatotic liver disease. | Commun Med (Lond) | 2025 | 40781351 | PubTator, text mining | PubMed |
| Fifteen Years of PNPLA3: Transforming Hepatology Through Human Genetics. | Liver Int | 2025 | 40747912 | PubTator, text mining | PubMed |
| Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning. | Front Genet | 2025 | 40747105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=12